CD8A and acute myeloid leukemia: In addition to AML, intertumoral and peripheral blood lymphocytes from HL patients also expressed high levels of LAG-3, and deletion of CD4+LAG-3+ T cells improved lymphoma-specific CD8+ T cell responses [107].